Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News DiaMedica Therapeutics Inc DMAC

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio... see more

Opinion & Analysis (NDAQ:DMAC)

No current opinion is available.

Bullboard Posts (NDAQ:DMAC)

DiaMedica Therapeutics Inc. (DMAC): Navigating the Challenge

http://beyondspx.com/2024/08/02/diamedica-therapeutics-inc-dmac-navigating-the-challenges-of-advancing-a-promising-stroke-treatment/
MikeTester - August 3, 2024

Here is something to think about to diversify.

Aristotle - 10 Cancers - One Sample of Blood Unlimited Possibilities. It's on the Toronto Stock Exchange in Canada. QR is about to be...
StockscoutX - February 3, 2021

C'mon Jinxmom

you spinless loser...enjoy your cr@p life...end it....we are having fun! 
TradeSaver2 - November 10, 2020

DiaMedica Therapeutics to Present at Conference

DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020 Link
StockscoutX - September 15, 2020

DiaMedica Announces First Patients Dosed

DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study Link
StockscoutX - September 15, 2020

over 100

Haha jinxmom - you are a loser. go off yourself. 
Carlsoncrew - June 19, 2020

Podcasts